GO:0004616 phosphogluconate dehydrogenase (decarboxylating) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004616 describes the molecular function that catalyzes the oxidative decarboxylation of 6-phospho-D-gluconate to D-ribulose 5-phosphate, producing CO2 and NADPH.
• This activity is the second NADPH-generating step of the pentose phosphate pathway and is encoded by the gene PGD in humans and GND1 in Saccharomyces cerevisiae.
• The enzyme is a homodimer with a classic Rossmann-fold NADP+ binding domain and a substrate-binding cleft that positions 6-phospho-D-gluconate for decarboxylation.
• Its activity is regulated by metabolic intermediates such as glucose 1,6-bisphosphate and by coordinate expression with glucose-6-phosphate dehydrogenase.
• Altered 6PGD activity has been observed in leukemic leukocytes and in adipose tissue of diabetic subjects, linking the enzyme to metabolic disease.
• In plants, a dehydrogenase-mediated NADPH recycling system in peroxisomes depends on 6PGD activity to maintain redox balance.
Description
Phosphogluconate dehydrogenase (decarboxylating) activity, classified under the Gene Ontology as GO:0004616, is a molecular function that catalyzes the reaction 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH + H+. This reaction is the second oxidative step of the pentose phosphate pathway and is a major source of NADPH for reductive biosynthesis and antioxidant defense. The enzyme responsible, 6-phosphogluconate dehydrogenase (6PGD), is widely conserved from bacteria to humans and has been purified and kinetically characterized from diverse sources including parsley leaves and Saccharomyces cerevisiae. Because it links carbon flux to NADPH production, 6PGD activity is of central interest to researchers studying cancer metabolism, diabetes, and redox biology. Understanding its mechanism, regulation, and genetic control is therefore essential for both basic and translational research.
phosphogluconate dehydrogenase (decarboxylating) activity At A Glance
| GO ID | GO:0004616 |
|---|---|
| GO term | phosphogluconate dehydrogenase (decarboxylating) activity |
| Ontology | molecular_function |
| Synonym | 6PGD activity; 6-phospho-D-gluconate dehydrogenase activity; 6-phosphogluconic dehydrogenase activity |
| Major function | Oxidative decarboxylation of 6-phospho-D-gluconate to D-ribulose 5-phosphate with concomitant NADPH production |
| Reaction | 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH + H+ |
| Cofactor | NADP+ (nicotinamide adenine dinucleotide phosphate) |
| Pathway context | Pentose phosphate pathway (oxidative phase) |
| Representative enzyme | 6-phosphogluconate dehydrogenase (6PGD); human gene PGD; yeast gene GND1 |
What Is GO:0004616?
GO:0004616 is defined as the catalysis of the reaction: 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH + H+. In other words, it is the enzyme activity that removes a carboxyl group from 6-phospho-D-gluconate (decarboxylation) while transferring electrons to NADP+, yielding the pentose phosphate D-ribulose 5-phosphate, carbon dioxide, and the reduced cofactor NADPH. This activity is synonymous with 6PGD activity, 6-phosphogluconate dehydrogenase activity, and 6-phosphogluconic dehydrogenase activity, among other names.
Why Is phosphogluconate dehydrogenase (decarboxylating) activity Important in Cell Biology?
GO:0004616 is important because it represents a key control point for NADPH supply and pentose phosphate pathway flux, which are essential for nucleotide biosynthesis, fatty acid synthesis, and maintenance of the cellular redox state. Its activity has been directly implicated in metabolic reprogramming: leukemic leukocytes show altered NADPH-forming enzyme activities, and adipose tissue from diabetic subjects displays changes in glucose-metabolizing enzymes including 6PGD. In plants, a dehydrogenase-mediated NADPH recycling system in peroxisomes relies on 6PGD activity to support antioxidant metabolism. Thus, understanding this activity helps explain how cells balance growth, biosynthesis, and stress defense.
• Provides NADPH for reductive biosynthesis and antioxidant systems.
• Second oxidative step of the pentose phosphate pathway, linking glucose metabolism to nucleotide precursor production.
• Altered activity in leukemic leukocytes suggests a role in cancer metabolism.
• Changes in adipose tissue of diabetic subjects link the enzyme to metabolic disease.
• Plant peroxisomal NADPH recycling depends on this activity for redox homeostasis.
• Regulated by glucose 1,6-bisphosphate, connecting glycolysis and the pentose phosphate pathway.
• Coordinate regulation with glucose-6-phosphate dehydrogenase ensures balanced pathway flux.
• Conserved structure and mechanism make it a model for dehydrogenase studies.
• Kinetic properties characterized in parsley leaves provide a basis for comparative enzymology.
• Histochemical methods allow localization of activity in tissue sections.
What Happens During phosphogluconate dehydrogenase (decarboxylating) activity?
Substrate binding and cofactor recruitment
In simple terms: The enzyme grabs its substrate and a helper molecule called NADP+.
The reaction begins when 6-phospho-D-gluconate binds to the active site of 6PGD and NADP+ occupies the Rossmann-fold cofactor-binding domain. Crystal structures of Saccharomyces cerevisiae Gnd1 reveal a homodimer with a deep substrate-binding cleft that positions the 6-phospho group for catalysis. Kinetic studies of the parsley enzyme confirm a sequential mechanism with NADP+ as the preferred cofactor.
Oxidative decarboxylation
In simple terms: The enzyme removes a carboxyl group and transfers electrons to NADP+.
Following binding, the enzyme catalyzes the oxidative decarboxylation of 6-phospho-D-gluconate, releasing CO2 and forming the pentose phosphate D-ribulose 5-phosphate. This step reduces NADP+ to NADPH, which is essential for reductive biosynthesis and redox defense. The reaction is irreversible under physiological conditions and represents a committed step in the oxidative phase of the pentose phosphate pathway.
Product release and pathway integration
In simple terms: The products are released and feed into other metabolic routes.
D-ribulose 5-phosphate is released and can be converted to ribose 5-phosphate for nucleotide synthesis or to xylulose 5-phosphate for the non-oxidative phase of the pentose phosphate pathway. NADPH is used in biosynthetic reactions and to regenerate reduced glutathione. The activity is coordinated with glucose-6-phosphate dehydrogenase to maintain pathway flux.
Regulation by metabolic intermediates
In simple terms: Small molecules can turn the enzyme up or down.
Glucose 1,6-bisphosphate inhibits 6PGD activity, providing a feedback link between glycolysis and the pentose phosphate pathway. Coordinate regulation with glucose-6-phosphate dehydrogenase ensures that NADPH production matches cellular demand. In plants, a dehydrogenase-mediated NADPH recycling system in peroxisomes depends on 6PGD activity for redox balance.
Key Genes Involved in GO:0004616 phosphogluconate dehydrogenase (decarboxylating) activity
The following genes encode proteins that carry out or directly support phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616) across model organisms and human cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PGD (human) | Encodes 6-phosphogluconate dehydrogenase, the enzyme responsible for GO:0004616 | Cancer metabolism, NADPH production, oxidative stress response |
| GND1 (Saccharomyces cerevisiae) | Encodes 6-phosphogluconate dehydrogenase; crystal structure determined | Structural and mechanistic studies of the enzyme |
| G6PD (human) | Encodes glucose-6-phosphate dehydrogenase, the first NADPH-producing enzyme of the pentose phosphate pathway | Coordinate regulation with 6PGD |
| H6PD (human) | Hexose-6-phosphate dehydrogenase, generates NADPH in the endoplasmic reticulum | Redox biology and metabolic disease |
| IDH1 (human) | Isocitrate dehydrogenase 1, cytosolic NADPH producer | Cancer metabolism, NADPH balance |
| IDH2 (human) | Isocitrate dehydrogenase 2, mitochondrial NADPH producer | Cancer metabolism, NADPH balance |
| ME1 (human) | Malic enzyme 1, cytosolic NADPH producer | Metabolic reprogramming in cancer |
| G6PD (Petroselinum hortense) | Glucose-6-phosphate dehydrogenase in parsley | Kinetic studies of pentose phosphate pathway enzymes |
| 6PGD (Petroselinum hortense) | 6-phosphogluconate dehydrogenase purified from parsley leaves | Kinetic characterization of plant 6PGD |
| Gnd1 (Saccharomyces cerevisiae) | 6-phosphogluconate dehydrogenase, decarboxylating | Structural biology of the enzyme |
| PGD (mouse) | Mouse ortholog of human PGD | Model organism studies of pentose phosphate pathway |
| PGD (rat) | Rat ortholog of human PGD | Enzyme activity assays in tissue sections |
| PGD (Drosophila melanogaster) | Drosophila 6-phosphogluconate dehydrogenase | Genetic studies of pentose phosphate pathway |
| PGD (Caenorhabditis elegans) | Nematode 6-phosphogluconate dehydrogenase | Redox and aging research |
| PGD (Arabidopsis thaliana) | Plant 6-phosphogluconate dehydrogenase | Peroxisomal NADPH recycling |
| PGD (Zea mays) | Maize 6-phosphogluconate dehydrogenase | Plant metabolic studies |
| PGD (Escherichia coli) | Bacterial 6-phosphogluconate dehydrogenase | Microbial metabolism and enzyme evolution |
How Is phosphogluconate dehydrogenase (decarboxylating) activity Regulated?
The activity of 6-phosphogluconate dehydrogenase (decarboxylating) is regulated at multiple levels. Metabolically, glucose 1,6-bisphosphate acts as an inhibitor, linking glycolytic flux to pentose phosphate pathway output. Coordinate regulation with glucose-6-phosphate dehydrogenase ensures that NADPH production is balanced with demand. In plants, a dehydrogenase-mediated NADPH recycling system in peroxisomes depends on 6PGD activity, indicating redox-sensitive control. Additionally, changes in enzyme activity have been observed in leukemic leukocytes and in adipose tissue of diabetic subjects, suggesting hormonal and metabolic regulation.
phosphogluconate dehydrogenase (decarboxylating) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PGD | Leukemia (altered NADPH-forming enzyme activities) | Knockout or overexpression in leukemic cell lines |
| PGD | Diabetes (altered adipose tissue enzyme activities) | Adipose-specific knockout in mouse models |
| PGD | Oxidative stress and redox imbalance | CRISPR knockout in cell lines followed by oxidative challenge |
| G6PD | Pentose phosphate pathway coordination | Double knockout with PGD to study pathway flux |
| GND1 | Fungal metabolism and structure-function | Yeast knockout and point mutations |
Cancer metabolism
Altered activities of NADPH-forming enzymes, including 6-phosphogluconate dehydrogenase, have been reported in leukemic leukocytes compared with normal leukocytes. Because 6PGD supports NADPH production and nucleotide precursor synthesis, its activity may contribute to the metabolic reprogramming of cancer cells.
Diabetes and metabolic disease
Enzymes of glucose metabolism and of the citrate cleavage pathway, including 6PGD, show altered activities in adipose tissue of diabetic subjects. This suggests that 6PGD activity may be relevant to insulin resistance and lipid metabolism.
Redox imbalance and oxidative stress
NADPH produced by 6PGD is used to regenerate reduced glutathione and maintain redox homeostasis. In plant peroxisomes, a dehydrogenase-mediated NADPH recycling system depends on 6PGD activity, highlighting its role in antioxidant defense.
From phosphogluconate dehydrogenase (decarboxylating) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 6PGD activity affect NADPH levels? | PGD knockout cell lines |
| How does a point mutation in the active site alter catalysis? | Point-mutation knock-in of PGD |
| Can tagged 6PGD be used to study localization? | Knock-in of fluorescent or affinity tags |
| Does overexpression of 6PGD increase NADPH production? | Overexpression cell models |
| What is the effect of 6PGD inhibition on cancer cell growth? | CRISPR knockout or small-molecule inhibition |
| How does 6PGD activity respond to metabolic stress? | Isogenic knockout and wild-type cells |
How to Study the phosphogluconate dehydrogenase (decarboxylating) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH absorbance assay | Enzyme activity via NADPH production at 340 nm | Purified enzyme or lysate kinetics |
| Histochemistry | Localization of enzyme activity in tissue sections | Tissue distribution studies |
| X-ray crystallography | Three-dimensional structure of the enzyme | Mechanistic and drug design studies |
| Kinetic assays | Km, Vmax, inhibition constants | Characterization of substrate and inhibitors |
| NADPH/NADP+ ratio measurement | Cellular redox state | Metabolic and oxidative stress studies |
| Glutathione assay | Antioxidant capacity | Redox biology |
| Western blot | Protein expression levels | Validation of knockout or overexpression |
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Cancer metabolism studies |
Enzyme activity assays
Direct spectrophotometric assays monitor NADPH production at 340 nm using purified enzyme or cell lysates, as performed for parsley 6PGD. Histochemical methods with semipermeable membranes allow localization of activity in tissue sections.
Structural biology
X-ray crystallography of Saccharomyces cerevisiae Gnd1 has revealed the homodimeric architecture and NADP+ binding site, providing a template for understanding the catalytic mechanism.
Kinetic characterization
Steady-state kinetic studies determine Km and Vmax for 6-phospho-D-gluconate and NADP+, and identify inhibitors such as glucose 1,6-bisphosphate.
Metabolic and redox profiling
Measurements of NADPH/NADP+ ratios, glutathione levels, and pentose phosphate pathway flux in cells with altered 6PGD activity reveal its contribution to redox balance.
How CRISPR Can Be Used to Study GO:0004616 phosphogluconate dehydrogenase (decarboxylating) activity
Knockout
CRISPR knockout of PGD eliminates 6-phosphogluconate dehydrogenase (decarboxylating) activity, allowing researchers to test its requirement for NADPH production, pentose phosphate pathway flux, and cell growth. Isogenic knockout lines are valuable for metabolic phenotyping.
Point Mutation
Point mutations in the active site of PGD can be introduced to dissect catalytic residues identified from crystal structures, such as those in Saccharomyces cerevisiae Gnd1. These models help distinguish catalytic defects from protein stability effects.
Knock-in
Knock-in of epitope or fluorescent tags at the endogenous PGD locus enables real-time localization and interaction studies without overexpression artifacts. Tagged knock-in lines also facilitate chromatin immunoprecipitation and proteomics.
Overexpression
Overexpression of wild-type or mutant PGD can test whether increased 6PGD activity drives NADPH production and supports growth under oxidative stress. Such models are useful for studying metabolic reprogramming in cancer and diabetes.
How EDITGENE Supports phosphogluconate dehydrogenase (decarboxylating) activity Research
Researchers studying phosphogluconate dehydrogenase (decarboxylating) activity-related genes often need to determine whether a candidate gene is causally involved in NADPH production, pentose phosphate pathway flux, or disease phenotypes. Rigorous causal inference requires well-controlled genetic models, including knockouts, point mutations, knock-ins, and overexpression lines, ideally in isogenic backgrounds.
Contact EDITGENE today to design your custom CRISPR model for phosphogluconate dehydrogenase (decarboxylating) activity research.
Frequently Asked Questions About phosphogluconate dehydrogenase (decarboxylating) activity
What is phosphogluconate dehydrogenase (decarboxylating) activity?
It is the enzyme activity defined by GO:0004616 that catalyzes the reaction 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH + H+.
What genes are involved in phosphogluconate dehydrogenase (decarboxylating) activity?
The main gene is PGD in humans, encoding 6-phosphogluconate dehydrogenase; in yeast it is GND1.
What is the role of 6PGD in the pentose phosphate pathway?
6PGD catalyzes the second oxidative step of the pentose phosphate pathway, producing NADPH and D-ribulose 5-phosphate.
How is 6-phosphogluconate dehydrogenase activity regulated?
It is inhibited by glucose 1,6-bisphosphate and coordinately regulated with glucose-6-phosphate dehydrogenase.
What diseases are associated with altered 6PGD activity?
Altered activity has been observed in leukemic leukocytes and in adipose tissue of diabetic subjects.
What is the reaction catalyzed by GO:0004616?
The reaction is 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH + H+.
What is the structure of 6-phosphogluconate dehydrogenase?
It is a homodimer with a Rossmann-fold NADP+ binding domain, as shown for Saccharomyces cerevisiae Gnd1.
How can I study 6PGD activity in the lab?
Common methods include NADPH absorbance assays, histochemistry, kinetics, and CRISPR knockout models.
Is 6PGD a good target for cancer research?
Its role in NADPH production and observed changes in leukemic cells make it a candidate for metabolic studies.
What CRISPR models are available for 6PGD research?
Knockout, point mutation, knock-in, and overexpression models can be generated to study GO:0004616.
Conclusion
GO:0004616, phosphogluconate dehydrogenase (decarboxylating) activity, is a central molecular function in the oxidative pentose phosphate pathway, responsible for producing NADPH and D-ribulose 5-phosphate. Its regulation by metabolites such as glucose 1,6-bisphosphate and its coordination with glucose-6-phosphate dehydrogenase highlight its integration into cellular metabolism. Altered activity in leukemia and diabetes underscores its clinical relevance. Researchers can now use CRISPR-based knockout, point-mutation, knock-in, and overexpression models to dissect its precise roles in health and disease.
References
- 1. Beitner R et al.. 1979. Inhibition of 6-phosphogluconate dehydrogenase (decarboxylating) by glucose 1,6-bisphosphate.. Biochim Biophys Acta 583(2):266-9 PMID: 375989
- 2. Pascual C et al.. 1982. Coordinate regulation of the pentose phosphate pathway and of the activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (decarboxylating).. Folia Microbiol (Praha) 27(6):365-9 PMID: 6757069
- 3. He W et al.. 2007. Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1.. BMC Struct Biol 7:38 PMID: 17570834
- 4. Meijer AE et al.. 1974. Semipermeable membranes for improving the histochemical demonstration of enzyme activities in tissue sections. IV. Glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (decarboxylating).. Histochemistry 40(4):349-59 PMID: 4139151
- 5. Demir H et al.. 2003. Purification of 6-phosphogluconate dehydrogenase from parsley (Petroselinum hortense) leaves and investigation of some kinetic properties.. Prep Biochem Biotechnol 33(1):39-52 PMID: 12693814
- 6. Belfiore F et al.. 1975. Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.. Clin Chem 21(7):880-3 PMID: 236846
- 7. Belfiore F et al.. 1975. Enzymes of glucose metabolism and of the citrate cleavage pathway in adipose tissue of normal and diabetic subjects.. Diabetes 24(10):865-73 PMID: 1183727
- 8. Corpas FJ et al.. 1998. A dehydrogenase-mediated recycling system of NADPH in plant peroxisomes.. Biochem J 330 ( Pt 2)(Pt 2):777-84 PMID: 9480890
